Opthea
Manufacturing · Australia · 11-50 Employees
View Company Info for Free
Overview
Headquarters
650 Chapel St L 4, South Yarra, Victoria...Website
www.opthea.comRevenue
<$5 MillionStock Symbol
OPTIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Opthea
Opthea is a biopharmaceutical company focused on developing innovative therapies to treat vision-threatening eye diseases, particularly wet age-related macular degeneration (AMD) and diabetic macular edema (DME). The company is engaged in pioneering research and clinical trials to improve sight in patients suffering from these conditions. Additionally, Opthea is exploring treatments for lymphangioleiomyomatosis (LAM), a rare disorder with significant unmet medical needs. Their target audience includes patients with retinal diseases and healthcare professionals involved in ophthalmology.Explore more
Opthea Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Opthea your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Opthea launches new products
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Opthea has new funding data
Check out if Opthea is spiking on competitors!
Earning: See what the market has to say on Opthea recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Opthea
Check if Opthea has recently received funding, and reach out quickly before it becomes old news!
Opthea, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Opthea had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Opthea as Masked Content
Find 3 more new buyers
Compare Similar Companies to Opthea
Compare insights from companies similar to Opthea, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Opthea is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Opthea is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Opthea.
Opthea financials insights
Gather financial insights about Opthea, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Stock Offering
$128M
2022
Debt
$170M
2023
Other Financing Round
$85M
Opthea Tech Stack
A closer look at the technologies used by Opthea
Most Recent Scoops
Left Company
Executive Move
Executive Moves, Left Company
Executive Move
Executive Moves, Board of Directors
Left Company
Executive Move
Executive Moves, Left Company
Lateral Move
Executive Move
Executive Moves, Lateral Move, Board of Directors
Left Company
Executive Move
Executive Moves, Left Company
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Opthea
Sign Up For FreeTo access detailed company insights
Opthea is a biopharmaceutical company focused on developing innovative therapies to treat vision-threatening eye diseases, particularly wet age-related macular degeneration (AMD) and diabetic macular edema (DME). The company is engaged in pioneering research and clinical trials to improve sight in patients suffering from these conditions. Additiona... Read More
